LETKO, BROSSEAU & ASSOCIATES INC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
LETKO, BROSSEAU & ASSOCIATES INC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$1,305,000
-87.6%
30,200
-87.9%
0.01%
-86.6%
Q2 2015$10,565,000
+9.0%
250,0000.0%0.10%
+5.4%
Q1 2015$9,695,000
+15.2%
250,0000.0%0.09%
+24.3%
Q4 2014$8,418,000
-3.8%
250,0000.0%0.07%0.0%
Q3 2014$8,755,000
+6.6%
250,0000.0%0.07%
+13.8%
Q2 2014$8,215,000
-10.9%
250,0000.0%0.06%
-17.7%
Q1 2014$9,215,000
-32.6%
250,000
-29.9%
0.08%
-30.1%
Q4 2013$13,679,000
+40.1%
356,4010.0%0.11%
+32.9%
Q3 2013$9,765,000
+36.2%
356,401
+4.4%
0.08%
+26.9%
Q2 2013$7,169,000341,4010.07%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders